The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ICLR FINANCIAL STATEMENTS

ICON PLC — balance sheet, income statement and cash flow trends

ICLRICON PLC

🇺🇸 USA · US · Healthcare · Diagnostics & Research

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
02.5 B5 B7.5 B202120222023202420252026

Profit Funnel

Q1 2026 · TTM
Revenue8.3 B $Gross Profit2 B $ · 24%Operating Income872.2 M $ · 11%Pre-tax Income206.3 M $ · 2%Net Income179.9 M $ · 2%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue8.3 B $+1.1%
Gross Profit2 B $-16.0%
Operating Income872.2 M $-15.5%
EBITDA773.1 M $-46.5%
Net Income179.9 M $-76.3%

Peer Comparison· Diagnostics & Research

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
ICLR1.1%24.1%9.3%2.2%
Industry median9.1%53.0%18.8%6.7%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
05 B10 B15 B202120222023202420252026

Capital Structure

Q1 2026
Total Assets16.3 B
  • Equity9.3 B $57%
  • Current Liabilities3.2 B $19%
  • Long-term Liabilities3.8 B $24%

Key Figures

YoY change
Total Assets16.3 B $-2.4%
Total Liabilities7 B $-2.8%
Total Equity9.3 B $-2.1%
Cash & ST Investments765.2 M $+45.3%
Total Debt3.5 B $-1.4%
Net Debt2.7 B $-9.5%

Peer Comparison· Diagnostics & Research

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
ICLR1.1437.7%3.5557.0%
Industry median1.8749.3%1.9250.1%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0500 M1 B202120222023202420252026

Cash Flow Bridge

Q1 2026 · TTM
0500 M1 B971.9 M $Operating-139.8 M $Investing-560 M $Financing272.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow971.9 M $-20.8%
Capital Expenditures181.4 M $+7.0%
Free Cash Flow790.5 M $-25.3%
Dividends Paid——

Peer Comparison· Diagnostics & Research

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
ICLR11.7%9.5%2.2%540.1%
Industry median16.3%9.7%4.5%110.1%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ICLR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. This content is for informational purposes only and is not investment advice.